isoproterenol has been researched along with Scleroderma, Systemic in 7 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Urea clearances were not significantly different from usual values." | 5.26 | Peritoneal clearances in scleroderma and diabetes mellitus: effects of intraperitioneal isoproterenol. ( Hirszel, P; Husted, FC; Miller, L; Nolph, KD, 1976) |
| "Urea clearances were not significantly different from usual values." | 1.26 | Peritoneal clearances in scleroderma and diabetes mellitus: effects of intraperitioneal isoproterenol. ( Hirszel, P; Husted, FC; Miller, L; Nolph, KD, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herlin, T | 1 |
| Eggert, J | 1 |
| Kragballe, K | 1 |
| Zachariae, H | 1 |
| Khokhova, IuV | 1 |
| Panasiuk, AF | 1 |
| Grozdova, MD | 1 |
| Kovacs, IB | 1 |
| Dowd, PM | 1 |
| Kirby, JD | 1 |
| Turner, P | 1 |
| Winkelmann, RK | 1 |
| Goldyne, ME | 1 |
| Linscheid, RL | 1 |
| Nolph, KD | 2 |
| Miller, L | 1 |
| Husted, FC | 1 |
| Hirszel, P | 1 |
| Emmanuel, G | 1 |
| Saroja, D | 1 |
| Gopinathan, K | 1 |
| Gharpure, A | 1 |
| Stuckey, J | 1 |
| Brown, ST | 1 |
| Ahearn, DJ | 1 |
7 other studies available for isoproterenol and Scleroderma, Systemic
| Article | Year |
|---|---|
Abnormal monocyte cytotoxicity and cyclic-AMP levels in systemic sclerosis.
Topics: Adult; Aged; Alprostadil; Antibody-Dependent Cell Cytotoxicity; Cyclic AMP; Female; Histamine; Human | 1984 |
[Effect of isoproterenol on collagen synthesis in cultured skin fibroblasts in patients with systemic scleroderma].
Topics: Adult; Bucladesine; Cells, Cultured; Collagen; Cyclic AMP; Fibroblasts; Humans; Isoproterenol; Middl | 1984 |
Cyclic adenine nucleotide levels in lymphocytes from patients with systemic sclerosis: efficiency of prostaglandin infusions.
Topics: Alprostadil; Cyclic AMP; Epoprostenol; Female; Humans; Isoproterenol; Lymphocytes; Male; Prostagland | 1983 |
Hypersensitivity of scleroderma cutaneous vascular smooth muscle to 5-hydroxytryptamine.
Topics: Adenosine Triphosphate; Adult; Arteries; Bradykinin; Dose-Response Relationship, Drug; Drug Hypersen | 1976 |
Peritoneal clearances in scleroderma and diabetes mellitus: effects of intraperitioneal isoproterenol.
Topics: Adult; Cell Membrane Permeability; Creatinine; Diabetes Mellitus; Female; Humans; Isoproterenol; Mid | 1976 |
Environmental factors and the diffusing capacity of the lung in progressive systemic sclerosis.
Topics: Acetylcholine; Blood Volume; Capillaries; Environment; Humans; Isoproterenol; Membranes; Muscle Tonu | 1976 |
Reduced peritoneal clearances in scleroderma increased by intraperitoneal isoproterenol.
Topics: Blood Urea Nitrogen; Capillary Permeability; Creatinine; Humans; Injections, Intraperitoneal; Isopro | 1973 |